Maintenance therapies in late-life depression: MTLD III
Phase of Trial: Phase IV
Latest Information Update: 26 Sep 2016
At a glance
- Drugs Donepezil (Primary) ; Antidepressants; Duloxetine; Escitalopram; Venlafaxine
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms MTLD-III
- 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Dec 2007 The expected completion date for this trial is now 1 Oct 2009.
- 07 Dec 2007 Status changed from recruiting to in progress.